We are live on
!
Find out more
CSCI
COSCIENS Biopharma Inc. Common Stock
CSCI
CSCI
Delisted
CSCI was delisted on the 3rd of September, 2025.
12 hedge funds and large institutions have $71.4K invested in COSCIENS Biopharma Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
0.07% less ownership
Funds ownership: 0.21% → 0.14% (-0.07%)
8% less funds holding
Funds holding: 13 → 12 (-1)
44% less capital invested
Capital invested by funds: $126K → $71.4K (-$55.1K)
92% less call options, than puts
Call options by funds: $48K | Put options by funds: $578K
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
3
Reduced
3
Closed
1
Calls
$48K
Puts
$578K
Net Calls
-$530K
Net Calls Change
+$1.78M
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$5.83K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.83K |
| 3 |
JP Morgan Chase
New York
|
+$266 |